Company Quest PharmaTech Inc. Other OTC

Stocks

QPTFF

CA74836M1068

Biotechnology & Medical Research

Business description: Quest PharmaTech Inc.

Sales by Activity: Quest PharmaTech Inc.

Executive Committee: Quest PharmaTech Inc.

Composition of the Board of Directors: Quest PharmaTech Inc.

Shareholders: Quest PharmaTech Inc.

Company details: Quest PharmaTech Inc.

Other Biotechnology & Medical Research

Sector

Inactive Instrument

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuestâ€™s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)

See all business segments

Manager	Title	Age	Since
Ragupathy Madiyalakan CEO	Chief Executive Officer	-	16/06/2004
Pierre Vermette DFI	Director of Finance/CFO	-	31/12/2004

See QUEST PHARMATECH INC. governance

Director	Title	Age	Since
Ragupathy Madiyalakan BRD	Director/Board Member	-	16/06/2004
J. Lievonen CHM	Chairman	-	04/07/2021
Jeffrey Shon BRD	Director/Board Member	-	04/07/2021
Bradley J Glass BRD	Director/Board Member	-	-

Composition of the Board of Directors

Name	Stocks	%	Valuation
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 14.78 %	25,000,000	14.78 %	350 000 $
Ragupathy Madiyalakan 1.892 %	3,200,000	1.892 %	44 800 $
Pierre Vermette 1.042 %	1,761,518	1.042 %	24 661 $
Jeffrey Shon 0.2069 %	350,000	0.2069 %	4 900 $
J. Lievonen 0 %	0	0 %	- $

List of QUEST PHARMATECH INC. shareholders

Quest PharmaTech, Inc.

97 Street NW

T6E 5R9, Edmonton

http://www.questpharmatech.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.09%	+5.26%	+4.44%	+26.03%	51.22B
REVOLUTION MEDICINES, INC.	-1.25%	+2.65%	+473.19%	+600.03%	45.38B
BEONE MEDICINES AG	+2.34%	+8.96%	+20.59%	+93.05%	41.97B
IQVIA HOLDINGS INC.	+1.08%	+9.39%	+39.64%	+20.77%	42.15B
CELLTRION, INC.	-0.93%	-4.80%	+17.39%	+46.60%	31.95B
ASCENDIS PHARMA A/S	+0.48%	+3.11%	-	-	16.73B
MEDPACE HOLDINGS, INC.	+1.75%	+7.24%	+36.84%	+152.20%	17.1B
EUROFINS SCIENTIFIC SE	+0.03%	+3.41%	+7.12%	+35.49%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.83%	+6.16%	+92.38%	+47.98%	13.91B
Average	+0.69%	+3.19%	+86.45%	+127.77%	30.58B
Weighted average by Cap.	+0.60%	+3.13%	+103.75%	+149.46%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research